Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE

Author:

Tsoukas Michael A.1ORCID,Woo Vincent2,Tobe Sheldon W.34,Slee April5,Rapattoni Wally6ORCID,Ang Fernando G.6,Seufert Jochen7ORCID,Neuen Brendon L.8ORCID,Arnott Clare891011ORCID,Mahaffey Kenneth W.12,Wheeler David C.13

Affiliation:

1. McGill University Health Centre Montreal Québec Canada

2. University of Manitoba Winnipeg Manitoba Canada

3. Sunnybrook Research Institute Toronto Ontario Canada

4. Northern Ontario School of Medicine Sudbury Ontario Canada

5. New Arch Consulting Seattle Washington USA

6. Janssen, Inc. Toronto Ontario Canada

7. Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine University of Freiburg Freiburg Germany

8. The George Institute for Global Health UNSW Sydney Sydney New South Wales Australia

9. Faculty of Medicine UNSW Sydney Sydney New South Wales Australia

10. Department of Cardiology Royal Prince Alfred Hospital Sydney New South Wales Australia

11. Sydney Medical School University of Sydney Sydney New South Wales Australia

12. Stanford Center for Clinical Research, Department of Medicine Stanford University School of Medicine Stanford California USA

13. Centre for Nephrology University College London London UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3